According to this study, the global Gene Synthesis market size will reach US$ 1923 million by 2031.
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
The gene synthesis market is experiencing robust growth, propelled by advancements in synthetic biology, personalized medicine, and biopharmaceutical development. Technological innovations such as CRISPR-based gene editing, automation, and high-throughput sequencing have streamlined the synthesis process, making it more efficient and cost-effective. These developments have expanded the applications of gene synthesis across various sectors, including healthcare, agriculture, and industrial biotechnology. In healthcare, for instance, gene synthesis is instrumental in developing targeted therapies and vaccines, while in agriculture, it aids in creating genetically modified crops with improved traits. The integration of artificial intelligence and machine learning further enhances the design and optimization of synthetic genes, accelerating research and development efforts.
Regionally, North America holds a significant share of the gene synthesis market, driven by substantial investments in research and development, a strong presence of key industry players, and supportive government policies. Asia-Pacific is emerging as a rapidly growing market, with countries like China and India investing heavily in biotechnology and synthetic biology initiatives. Despite the promising growth, the market faces challenges such as ethical concerns, regulatory hurdles, and the high cost of gene synthesis technologies. Addressing these issues through transparent policies, public engagement, and continued technological advancements will be crucial for the sustained expansion of the gene synthesis market.
The 鈥淕ene Synthesis Industry Forecast鈥� looks at past sales and reviews total world Gene Synthesis sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Synthesis sales for 2025 through 2031. With Gene Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Synthesis industry.
This Insight Report provides a comprehensive analysis of the global Gene Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Gene Synthesis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Synthesis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Synthesis.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Synthesis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Below 1000 bp
1001-3000 bp
3001-5000 bp
Above 5000 bp
Segmentation by Application:
Commercial
Academic Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Genescript
Thermo Scientific
IDT
Eurofins Genomics
DNA 2.0 (ATUM)
BBI
Azenta Life Sciences
SBS Genetech
Bio Basic
Twist Bioscience
OriGene
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Gene Synthesis 麻豆原创 Size (2020-2031)
2.1.2 Gene Synthesis 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Synthesis by Country/Region (2020, 2024 & 2031)
2.2 Gene Synthesis Segment by Type
2.2.1 Below 1000 bp
2.2.2 1001-3000 bp
2.2.3 3001-5000 bp
2.2.4 Above 5000 bp
2.3 Gene Synthesis 麻豆原创 Size by Type
2.3.1 Gene Synthesis 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Synthesis 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Gene Synthesis Segment by Application
2.4.1 Commercial
2.4.2 Academic Research
2.5 Gene Synthesis 麻豆原创 Size by Application
2.5.1 Gene Synthesis 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Synthesis 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Gene Synthesis 麻豆原创 Size by Player
3.1 Gene Synthesis 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Gene Synthesis Revenue by Player (2020-2025)
3.1.2 Global Gene Synthesis Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Gene Synthesis Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Synthesis by Region
4.1 Gene Synthesis 麻豆原创 Size by Region (2020-2025)
4.2 Global Gene Synthesis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Synthesis 麻豆原创 Size Growth (2020-2025)
4.4 APAC Gene Synthesis 麻豆原创 Size Growth (2020-2025)
4.5 Europe Gene Synthesis 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Gene Synthesis 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Gene Synthesis 麻豆原创 Size by Country (2020-2025)
5.2 Americas Gene Synthesis 麻豆原创 Size by Type (2020-2025)
5.3 Americas Gene Synthesis 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Synthesis 麻豆原创 Size by Region (2020-2025)
6.2 APAC Gene Synthesis 麻豆原创 Size by Type (2020-2025)
6.3 APAC Gene Synthesis 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene Synthesis 麻豆原创 Size by Country (2020-2025)
7.2 Europe Gene Synthesis 麻豆原创 Size by Type (2020-2025)
7.3 Europe Gene Synthesis 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Synthesis by Region (2020-2025)
8.2 Middle East & Africa Gene Synthesis 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Gene Synthesis 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Gene Synthesis 麻豆原创 Forecast
10.1 Global Gene Synthesis Forecast by Region (2026-2031)
10.1.1 Global Gene Synthesis Forecast by Region (2026-2031)
10.1.2 Americas Gene Synthesis Forecast
10.1.3 APAC Gene Synthesis Forecast
10.1.4 Europe Gene Synthesis Forecast
10.1.5 Middle East & Africa Gene Synthesis Forecast
10.2 Americas Gene Synthesis Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Gene Synthesis Forecast
10.2.2 Canada 麻豆原创 Gene Synthesis Forecast
10.2.3 Mexico 麻豆原创 Gene Synthesis Forecast
10.2.4 Brazil 麻豆原创 Gene Synthesis Forecast
10.3 APAC Gene Synthesis Forecast by Region (2026-2031)
10.3.1 China Gene Synthesis 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Gene Synthesis Forecast
10.3.3 Korea 麻豆原创 Gene Synthesis Forecast
10.3.4 Southeast Asia 麻豆原创 Gene Synthesis Forecast
10.3.5 India 麻豆原创 Gene Synthesis Forecast
10.3.6 Australia 麻豆原创 Gene Synthesis Forecast
10.4 Europe Gene Synthesis Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Gene Synthesis Forecast
10.4.2 France 麻豆原创 Gene Synthesis Forecast
10.4.3 UK 麻豆原创 Gene Synthesis Forecast
10.4.4 Italy 麻豆原创 Gene Synthesis Forecast
10.4.5 Russia 麻豆原创 Gene Synthesis Forecast
10.5 Middle East & Africa Gene Synthesis Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Gene Synthesis Forecast
10.5.2 South Africa 麻豆原创 Gene Synthesis Forecast
10.5.3 Israel 麻豆原创 Gene Synthesis Forecast
10.5.4 Turkey 麻豆原创 Gene Synthesis Forecast
10.6 Global Gene Synthesis Forecast by Type (2026-2031)
10.7 Global Gene Synthesis Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Gene Synthesis Forecast
11 Key Players Analysis
11.1 Genescript
11.1.1 Genescript Company Information
11.1.2 Genescript Gene Synthesis Product Offered
11.1.3 Genescript Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Genescript Main Business Overview
11.1.5 Genescript Latest Developments
11.2 Thermo Scientific
11.2.1 Thermo Scientific Company Information
11.2.2 Thermo Scientific Gene Synthesis Product Offered
11.2.3 Thermo Scientific Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Thermo Scientific Main Business Overview
11.2.5 Thermo Scientific Latest Developments
11.3 IDT
11.3.1 IDT Company Information
11.3.2 IDT Gene Synthesis Product Offered
11.3.3 IDT Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 IDT Main Business Overview
11.3.5 IDT Latest Developments
11.4 Eurofins Genomics
11.4.1 Eurofins Genomics Company Information
11.4.2 Eurofins Genomics Gene Synthesis Product Offered
11.4.3 Eurofins Genomics Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Eurofins Genomics Main Business Overview
11.4.5 Eurofins Genomics Latest Developments
11.5 DNA 2.0 (ATUM)
11.5.1 DNA 2.0 (ATUM) Company Information
11.5.2 DNA 2.0 (ATUM) Gene Synthesis Product Offered
11.5.3 DNA 2.0 (ATUM) Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 DNA 2.0 (ATUM) Main Business Overview
11.5.5 DNA 2.0 (ATUM) Latest Developments
11.6 BBI
11.6.1 BBI Company Information
11.6.2 BBI Gene Synthesis Product Offered
11.6.3 BBI Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 BBI Main Business Overview
11.6.5 BBI Latest Developments
11.7 Azenta Life Sciences
11.7.1 Azenta Life Sciences Company Information
11.7.2 Azenta Life Sciences Gene Synthesis Product Offered
11.7.3 Azenta Life Sciences Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Azenta Life Sciences Main Business Overview
11.7.5 Azenta Life Sciences Latest Developments
11.8 SBS Genetech
11.8.1 SBS Genetech Company Information
11.8.2 SBS Genetech Gene Synthesis Product Offered
11.8.3 SBS Genetech Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 SBS Genetech Main Business Overview
11.8.5 SBS Genetech Latest Developments
11.9 Bio Basic
11.9.1 Bio Basic Company Information
11.9.2 Bio Basic Gene Synthesis Product Offered
11.9.3 Bio Basic Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Bio Basic Main Business Overview
11.9.5 Bio Basic Latest Developments
11.10 Twist Bioscience
11.10.1 Twist Bioscience Company Information
11.10.2 Twist Bioscience Gene Synthesis Product Offered
11.10.3 Twist Bioscience Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Twist Bioscience Main Business Overview
11.10.5 Twist Bioscience Latest Developments
11.11 OriGene
11.11.1 OriGene Company Information
11.11.2 OriGene Gene Synthesis Product Offered
11.11.3 OriGene Gene Synthesis Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 OriGene Main Business Overview
11.11.5 OriGene Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
